Literature DB >> 7548495

Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera.

J Echevarría1, C Seas, C Carrillo, R Mostorino, R Ruiz, E Gotuzzo.   

Abstract

We conducted a randomized double-blinded study in Lima, Peru, to assess the tolerability and efficacy of a single 250-mg dose of ciprofloxacin in preventing diarrhea and Vibrio cholerae O1 infection among household contacts of bacteriologically confirmed index cases. Adult household contacts with negative baseline stool cultures were included. A total of 213 household contacts were evaluable. The study drugs were well tolerated in both groups. Ciprofloxacin did not prevent the acquisition of V. cholerae O1 infection nor the development of diarrhea. However, in a subgroup of 30 household contacts with positive baseline stool cultures a reduction in the bacterial load and a trend toward prevention of diarrhea were observed among ciprofloxacin recipients. When all household contacts were evaluated, a trend toward prevention of diarrhea was observed with the prophylactic regimen. Ciprofloxacin failed to prevent V. cholerae O1 infections during a period of low transmissibility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548495     DOI: 10.1093/clinids/20.6.1480

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  New developments in the understanding of cholera.

Authors:  T Butler
Journal:  Curr Gastroenterol Rep       Date:  2001-08

2.  Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh.

Authors:  Ana A Weil; Yasmin Begum; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Regina C LaRocque; Richelle C Charles; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Am J Trop Med Hyg       Date:  2014-08-11       Impact factor: 2.345

3.  Clinical outcomes in household contacts of patients with cholera in Bangladesh.

Authors:  Ana A Weil; Ashraful I Khan; Fahima Chowdhury; Regina C Larocque; A S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

Review 4.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 5.  Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.

Authors:  Ludovic Reveiz; Evelina Chapman; Pilar Ramon-Pardo; Tracey Perez Koehlmoos; Luis Gabriel Cuervo; Sylvain Aldighieri; Amy Chambliss
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

6.  Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak.

Authors:  Joseph A Lewnard; Marina Antillón; Gregg Gonsalves; Alice M Miller; Albert I Ko; Virginia E Pitzer
Journal:  PLoS Med       Date:  2016-01-26       Impact factor: 11.069

7.  The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.

Authors:  Flavio Finger; Enrico Bertuzzo; Francisco J Luquero; Nathan Naibei; Brahima Touré; Maya Allan; Klaudia Porten; Justin Lessler; Andrea Rinaldo; Andrew S Azman
Journal:  PLoS Med       Date:  2018-02-27       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.